|
gptkbp:instance_of
|
gptkb:healthcare_organization
|
|
gptkbp:bfsLayer
|
5
|
|
gptkbp:bfsParent
|
gptkb:Leishmania_species
gptkb:Kinetoplastea
gptkb:Kinetoplastids
gptkb:Leishmania_braziliensis
gptkb:Leishmania_infantum
|
|
gptkbp:affects
|
gptkb:Person
gptkb:dog_breed
rodents
other mammals
|
|
gptkbp:case_types
|
estimated 1 million cases annually
|
|
gptkbp:casualties
|
estimated 20,000 deaths annually
|
|
gptkbp:caused_by
|
gptkb:Leishmania_parasites
|
|
gptkbp:communication
|
sandflies
|
|
gptkbp:distribution
|
gptkb:South_America
East Africa
Mediterranean region
South Asia
tropical regions
subtropical regions
|
|
gptkbp:healthcare
|
in many developing countries
in refugee populations
in urban slums
|
|
gptkbp:historical_event
|
first described in 1911
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Leishmaniasis
|
|
gptkbp:is_protected_by
|
gptkb:mythological_figure
vector control
bed nets
|
|
gptkbp:research_focus
|
new treatment options
vaccine development
vector control strategies
|
|
gptkbp:risk_factor
|
malnutrition
immunosuppression
HIV infection
living in endemic areas
|
|
gptkbp:scientific_classification
|
neglected tropical disease
|
|
gptkbp:social_responsibility
|
clinical examination
serological tests
PCR testing
|
|
gptkbp:symptoms
|
gptkb:fandom
weight loss
fever
skin ulcers
|
|
gptkbp:treatment
|
gptkb:amphotericin_B
gptkb:miltefosine
antimonial compounds
|
|
gptkbp:type_of
|
gptkb:cutaneous_leishmaniasis
mucocutaneous leishmaniasis
visceral leishmaniasis
|